Literature DB >> 34762101

Understanding the Implications of Medicaid Expansion for Cancer Care in the US: A Review.

Theresa Ermer1,2,3, Samantha L Walters3, Maureen E Canavan3,4, Michelle C Salazar5,6, Andrew X Li5, Michael Doonan7, Daniel J Boffa3.   

Abstract

IMPORTANCE: Insurance status has been linked to important differences in cancer treatment and outcomes in the US. With more than 15 million individuals gaining health insurance through Medicaid expansion, there is an increasing need to understand the implications of this policy within the US cancer population. This review provides an overview of the fundamental principles and nuances of Medicaid expansion, as well as the implications for cancer care. OBSERVATIONS: The Patient Protection and Affordable Care Act presented states with an option to expand Medicaid coverage by broadening the eligibility criteria (eg, raising the eligible income level). During the past 10 years, Medicaid expansion has been credited with a 30% reduction in the population of uninsured individuals in the US. Such a significant change in the insurance profile could have important implications for the 1.7 million patients diagnosed with cancer each year, the oncology teams that care for them, and policy makers. However, several factors may complicate efforts to characterize the effect of Medicaid expansion on the US cancer population. Most notably, there is considerable variation among states in terms of whether Medicaid expansion took place, when expansion occurred, eligibility criteria for Medicaid, and coverage types that Medicaid provides. In addition, economic and health policy factors may be intertwined with factors associated with Medicaid expansion. Finally, variability in the manner in which cancer care has been captured and depicted in large databases could affect the interpretation of findings associated with expansion. CONCLUSIONS AND RELEVANCE: The expansion of Medicaid was a historic public policy initiative. To fully leverage this policy to improve oncological care and to maximize learning for subsequent policies, it is critical to understand the effect of Medicaid expansion. This review aims to better prepare investigators and their audiences to fully understand the implications of this important health policy initiative.

Entities:  

Mesh:

Year:  2022        PMID: 34762101     DOI: 10.1001/jamaoncol.2021.4323

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


  6 in total

1.  Association Between Medicaid Expansion Under the Affordable Care Act and Survival Among Newly Diagnosed Cancer Patients.

Authors:  Xuesong Han; Jingxuan Zhao; K Robin Yabroff; Christopher J Johnson; Ahmedin Jemal
Journal:  J Natl Cancer Inst       Date:  2022-08-08       Impact factor: 11.816

2.  Association of Insurance Status and Extent of Organ Involvement With Survival Among Patients With Stage IV Cancer.

Authors:  Peter L Zhan; Maureen E Canavan; Theresa Ermer; Matthew D Pichert; Andrew X Li; Richard C Maduka; Daniel J Boffa
Journal:  JAMA Netw Open       Date:  2022-06-01

3.  Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US.

Authors:  Theresa Ermer; Maureen E Canavan; Richard C Maduka; Andrew X Li; Michelle C Salazar; Michael F Kaminski; Matthew D Pichert; Peter L Zhan; Vincent Mase; Harriet Kluger; Daniel J Boffa
Journal:  JAMA Netw Open       Date:  2022-06-01

4.  Financial toxicity in hematological malignancies: a systematic review.

Authors:  Evguenia Ouchveridze; Rahul Banerjee; Aakash Desai; Muhammad Aziz; Wade Lee-Smith; Hira Mian; Katherine Berger; Brian McClune; Douglas Sborov; Muzaffar Qazilbash; Shaji Kumar; Ghulam Rehman Mohyuddin
Journal:  Blood Cancer J       Date:  2022-04-22       Impact factor: 9.812

5.  Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung Cancer.

Authors:  Matthew D Pichert; Maureen E Canavan; Richard C Maduka; Andrew X Li; Theresa Ermer; Peter L Zhan; Michael Kaminski; Brooks V Udelsman; Justin D Blasberg; Henry S Park; Sarah B Goldberg; Daniel J Boffa
Journal:  JAMA Netw Open       Date:  2022-08-01

6.  Obamacare: A bibliometric perspective.

Authors:  Alvaro Carrasco-Aguilar; José Javier Galán; Ramón Alberto Carrasco
Journal:  Front Public Health       Date:  2022-08-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.